Learn About Advance Care Planning on CME Webcast

OSUWexnerbloglogo2014 Learn About Advance Care Planning on CME Webcast. We have come a long way in the evolution of advance directives but it is still common for patients, physicians, and families to be faced with having to make a sudden decision about whether to institute life-saving measures. Particularly because sometimes those measures do less to prolong life than to prolong the process of death. Joining us today to help all of us become better at proactively discussing advance directives with our patients is palliative medicine specialist and Assistant Professor of Internal Medicine, Dr. Kavitha Norton.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: define Advance Care Planning as Communication Process for Patient Empowerment; and discuss components and products of Advance Care Planning including proxy and health documents.

You’ll also learn about the following:

  • DNR, DNR-CCA, & DNR-CC
  • Starting the advance care directive discussion
  • Common definition of Advance Care Planning & Framework
  • Challenges with Advance Care Planning
  • Tools and resources for these discussions
  • Documenting

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses The Red Eye Differential Diagnosis and Treatment

OSUWexnerbloglogo2014 CME Webcast Discusses The Red Eye: Differential Diagnosis and Treatment. Today on MedNet21, we’re going to review the causes of red eyes in order to help you make a prompt diagnosis and get your patients started on the right treatment. We’re pleased to welcome back Assistant Professor of Ophthalmology, Dr. Tyler Oostra.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize and diagnosis common causes of red eye; and know when to refer patients with red eyes for further care.

You’ll also learn about the following:

  • Most common causes of red eyes
  • Red eye red flags
  • Bacterial versus viral conjunctivitis
  • Isolation of children with viral conjunctivitis
  • When shingles affects the eye
  • Diagnostic significance of bilateral versus unilateral red eye
  • Causes of dry eyes

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Cardiac Non-Invasive Testing On Webcast

OSUWexnerbloglogo2014 Learn About Cardiac Non-Invasive Testing On Webcast. Today on MedNet21, we are going to update you on the currently used tests to non-invasively identify patients with ischemic heart disease. To tell us about stress test options, we’re pleased to welcome cardiologist and Assistant Professor of Internal Medicine Dr. Bryan Lee. And then to tell us about the role of cardiac CT and MRI, we have cardiologist and Assistant Professor of Internal Medicine, Dr. Salman Bhatti.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe how to assess the pre-test likelihood of coronary artery disease by history; and understand the advantages and pitfalls between the different modalities; recognize when it is appropriate to order a stress test; and understand how different stress modalities compare with each other, their advantages and disadvantages and when to use one over the other.

You’ll also learn about the following:

  • Cardiac stress test selection
  • Cardiac CT & MRI
  • Common indications for cardiac MRI
  • Training required to read cardiac CT & MRI

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Teaches on Systemic Lupus Erythematosus: Diagnosis and Management

OSUWexnerbloglogo2014 Webcast Teaches on Systemic Lupus Erythematosus: Diagnosis and Management. Despite all of these discoveries, systemic lupus erythematosus in many ways continues to be a mystery. The causes are not clear and the clinical manifestations are so protean that a confident diagnosis can often be hard to make. But the good news is that we now have new treatments for lupus that are improving patients’ lives in ways that were previously not possible. Let me welcome today’s guest. Dr. Judith Lin is a rheumatologist and Assistant Professor of Internal Medicine at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: identify clinical manifestations and immunologic features of SLE; and recognize that management of SLE treatment depends on disease activity and areas being affected, and learn to assess comorbid conditions and complications.

You’ll also learn about the following:

  • The ANA test
  • New treatments for systemic lupus erythematosus

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Lymphadenopathy and New Treatments for Lymphoproliferative Disorders

OSUWexnerbloglogo2014 Learn About Lymphadenopathy and New Treatments for Lymphoproliferative Disorders. Today on MedNet21, we are going to bring you up to date on the approach to lymphadenopathy and then tell you about some exciting new treatments for lymphoma that are changing the management of the disease. Our guests today are hematologist and Assistant Professor of Internal medicine, Dr. David Bond. And also Assistant Professor of Internal Medicine from the Division of Hematology, Dr. Yazeed Sawalha.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: review the mechanisms
of action and clinical data of (CAR) T cells and BiTEs in patients with relapsed/refractory B-cell non-Hodgkin lymphoma; highlight unique toxicities associated with CAR T cells and BiTEs: cytokines release syndrome and neurotoxicity; recognize the leading differential diagnosis considerations for a patient presenting with undifferentiated lymphadenopathy; and Differentiate diagnostic biopsy approaches including fine needle aspiration, core needle biopsy, and excisional lymph node biopsy.

You’ll also learn about the following:

  • New treatments for lymphoma
  • Cost and insurance coverage for CAR T-cells and bispecific T-cell engagers
  • What patients should expect during treatment
  • Stem cell transplant timing
  • Stem cell transplant versus bone marrow transplant

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.